FDA Updates Active Ingredient Guidance For New Drug Studies
The U.S. Food and Drug Administration on Monday released important guidance on the testing of new prescription drugs before and after approval, explaining its current thinking on how manufacturers can show...To view the full article, register now.
Already a subscriber? Click here to view full article